Discovery of dibenzyl amide derivatives as novel CXCR4 modulators against inflammatory bowel disease

The CXCR4/CXCL12 chemokine axis demonstrates significant potential in the treatment of inflammatory bowel disease (IBD) due to its crucial roles in inflammatory and immune responses. Modulating the CXCR4/CXCL12 pathway can be an effective therapeutic approach to ameliorate the inflammatory state of...

Full description

Bibliographic Details
Main Authors: Xiaoying Jiang, Liuxin Lu, Jiahui Wang, Meng Yu, Rui Wu, Rui Zhao, Hao Wen, Renren Bai
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:European Journal of Medicinal Chemistry Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772417424000062

Similar Items